---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-043989"
form_type: "8-K"
ticker: "VTGN"
cik: "0001411685"
company_name: "Vistagen Therapeutics, Inc."
filed_at: "2026-06-17T21:13:49+00:00"
generated_at: "2026-06-17T21:16:35.895234+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Two Vistagen directors will not stand for re-election at 2026 Annual Meeting

## Summary
- Margaret FitzPatrick (June 16) and Joanne Curley (June 17) notified Vistagen they will not stand for re-election.
- Both will continue serving as directors until the end of their terms at the 2026 Annual Meeting.
- No replacements have been announced; board composition will change after the meeting.

## SEC filing metadata
- accession: 0001628280-26-043989
- form_type: 8-K
- ticker: VTGN
- cik: 0001411685
- company_name: Vistagen Therapeutics, Inc.
- filed_at: 2026-06-17T21:13:49+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1411685/000162828026043989/0001628280-26-043989-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1411685/000162828026043989/vtgn-20260616.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-043989
- JSON: https://secwatch.observer/filing/0001628280-26-043989.json
- Plain text: https://secwatch.observer/filing/0001628280-26-043989.txt

## Key facts
- Executive change
  Joanne Curley departed as Director at Vistagen Therapeutics, Inc..
  - Action: not stand for re-election
  - Role: Director
  source text: On June 16, 2026, Ms. Margaret FitzPatrick, and on June 17, 2026, Dr. Joanne Curley, each a member of the Board of Directors of Vistagen Therapeutics, Inc. (the “ Company ”), notified the Company of her decision not to stand for re-election at the Company’s 2026 Annual Meeting of Stockholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1411685/000162828026043989/0001628280-26-043989-index.htm
- Executive change
  Margaret FitzPatrick departed as Director at Vistagen Therapeutics, Inc..
  - Action: not stand for re-election
  - Role: Director
  source text: On June 16, 2026, Ms. Margaret FitzPatrick, and on June 17, 2026, Dr. Joanne Curley, each a member of the Board of Directors of Vistagen Therapeutics, Inc. (the “ Company ”), notified the Company of her decision not to stand for re-election at the Company’s 2026 Annual Meeting of Stockholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1411685/000162828026043989/0001628280-26-043989-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.